New Video: See How Apligraf® Transforms Chronic Wounds

Rediscover healing that remains ahead of its time.

Learn about Apligraf®

Bioengineered with living cells to transform wounds from chronic to acute, Apligraf is a skin substitute that's backed by unmatched clinical evidence in healing VLUs and DFUs.1-8

DFU=diabetic foot ulcer; VLU=venous leg ulcer

Apligraf is an innovation
that remains ahead of its time

Even after 20 years, Apligraf continues to be the biotech healer for stalled VLUs and DFUs. Watch the 30-second overview of Apligraf to learn about unmatched clinical evidence and unsurpassed access for your patients.2-8

Why Apligraf

See how Apligraf transforms
wounds from chronic to acute

Take a closer look at how the mechanism of action of Apligraf helps to heal VLUs and DFUs faster.1-8

Apligraf mechanism of action

See how Apligraf heals

Ready to start healing stalled wounds?

Talk to an Organogenesis Tissue Regeneration Specialist about using Apligraf to help close stalled VLUs and DFUs faster.2-8

Contact us

The timeless quality of proven results

Randomized controlled trials and real-world observational studies continue to demonstrate that Apligraf closes more VLUs and DFUs faster, which can lead to lower healthcare costs.2-10

Clinical trials
Real-world evidence
Health economic analyses

See a short video on how Apligraf can help reduce the real costs of VLUs and DFUs.10

Video on the real costs of VLUs
Video on the real costs of DFUs

Unsurpassed access for patients*

100%

of Medicare contractors cover Apligraf treatment for VLUs and DFUs8

View Medicare coverage details

100%

of commercial medical policies cover Apligraf treatment for VLUs and DFUs8

View commercial coverage details
The coverage information provided shall not be construed as a statement, promise, or guarantee that reimbursement will be received. Reimbursement requirements are subject to change at any time. Check with your local payer regularly. *Insurance coverage varies by payer and is subject to change at any time. Confirm with your current applicable payer policies for up-to-date Apligraf coverage requirements and policies.

Please refer to the Apligraf Package Insert for complete prescribing information.

REFERENCES:

  1. Stone RC, et al. Sci Transl Med. 2017;9(371). doi:10.1126/scitranslmed.aaf8611
  2. Apligraf [package insert]. Canton, MA: Organogenesis Inc; 2017.
  3. Marston WA, et al. Wound Repair Regen. 2014;22(3):334-340.
  4. Treadwell T, et al. Adv Wound Care. 2018;7(3):69-76.
  5. Sabolinski ML, et al. J Comp Eff Res. 2018;7(8):797-805.
  6. Veves A, et al. Diabetes Care. 2001;24(2):290-295.
  7. Kirsner RS, et al. Wound Repair Regen. 2015;23(5):737-744.
  8. Data on file. Organogenesis Inc.
  9. Schonfeld WH, et al. Wound Repair Regen. 2000;8:251-257.
  10. Rice JB, et al. J Med Econ. 2015;18(8):586-595.